Neurocranial Emboli Removal Systems with Artificial Intelligence and Robotics

Publication ID: 24-11857209_0005_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Neurocranial Emboli Removal Systems with Artificial Intelligence and Robotics,” Published Technical Disclosure No. 24-11857209_0005_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857209_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,209.

Summary of the Inventive Concept

The present inventive concept relates to a next-generation system for neurocranial emboli removal, integrating catheter-based emboli removal devices with artificial intelligence-powered navigation, micro-robotic systems, and real-time imaging for enhanced precision and efficacy.

Background and Problem Solved

The original patent's minimally invasive catheter and methods of minimally invasive catheter delivered embolic capture devices have limitations in terms of precision, efficacy, and complexity. The present inventive concept addresses these limitations by incorporating advanced technologies to provide a more efficient, precise, and automated system for neurocranial emboli removal.

Detailed Description of the Inventive Concept

The inventive concept comprises a catheter-based emboli removal device with a self-expanding mesh basket and an artificial intelligence-powered navigation system for real-time emboli tracking and optimized device deployment. The device is integrated with a micro-robotic system for emboli dislodgement and removal, and utilizes machine learning algorithms to predict and prevent distal complications. The system also features a real-time imaging system for enhanced visualization and precision. In an alternative embodiment, the device can be configured with a hybrid catheter-robotic system with a flexible, shape-memory alloy-based emboli removal device.

Novelty and Inventive Step

The new claims introduce the integration of artificial intelligence, micro-robotics, and real-time imaging, which are not present in the original patent. These advancements provide a significant improvement in precision, efficacy, and automation, making the inventive concept novel and non-obvious compared to the original patent.

Alternative Embodiments and Variations

Other embodiments of the inventive concept could include the use of nanotechnology-enhanced mesh baskets, onboard computer systems with advanced machine learning algorithms for autonomous navigation, and real-time feedback from a patient's vital signs to optimize device performance. The inventive concept could also be adapted for treating pulmonary embolism or other vascular diseases.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of neurointerventional and cardiovascular medicine. The target market includes hospitals, clinics, and medical research institutions, with potential for expansion into other vascular disease treatment areas.

CPC Classifications

SectionClassGroup
A A61 A61B17/22012
A A61 A61B17/221
A A61 A61B2017/22038
A A61 A61B2017/22084

Field of Art

Interventional medical devices, specifically minimally invasive catheter systems for vascular intervention and embolic capture in neurovascular and peripheral vascular applications

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or interventional medical device designer with expertise in catheter design, vascular intervention techniques, advanced materials, and emerging medical technologies with knowledge of mechanical engineering, robotics, and medical imaging

Obviousness Rationale

A PHOSITA would recognize that integrating artificial intelligence, micro-robotics, and advanced imaging into existing embolic capture device designs represents a predictable technological evolution driven by ongoing advancements in medical device automation and precision interventional techniques. The fundamental structural and functional elements of the source patent's embolic capture device provide a clear technical foundation for incorporating intelligent navigation and robotic control systems. These enhancements represent incremental improvements using known techniques in medical device design that would be obvious to a skilled practitioner seeking to optimize device performance and clinical outcomes.

Obvious Combinations & Variations

Source Patent Element
Elongated stent body with self-expanding mesh basket for embolic capture
PTD Variation
Integration of AI-powered navigation system and micro-robotic control for precise device deployment and emboli removal
Obviousness Reasoning
Adding intelligent control systems to existing medical device designs is a predictable technological progression using known robotics and machine learning techniques to enhance clinical precision
Source Patent Element
Catheter-based device with axial lumen and configurable cell structures
PTD Variation
Hybrid catheter-robotic system using shape-memory alloy materials for flexible emboli removal
Obviousness Reasoning
Modifying device materials and incorporating robotic elements represents a standard design approach for improving device performance and adaptability in interventional medical technologies
Source Patent Element
Minimally invasive embolic capture device for vascular intervention
PTD Variation
Real-time imaging integration and machine learning algorithms for autonomous navigation and complication prediction
Obviousness Reasoning
Enhancing medical devices with advanced imaging and predictive analytics is a known technique for improving diagnostic and interventional capabilities using standard engineering approaches
Source Patent Element
Stent body with configurable cell structures and strut profiles
PTD Variation
Nanotechnology-enhanced mesh baskets with adaptive material properties for improved emboli capture
Obviousness Reasoning
Applying emerging materials science techniques to existing device designs represents a predictable innovation path for improving medical device performance
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857209 and the disclosed technical variations, a person having ordinary skill in the art would find the proposed embolic capture device innovations obvious and lacking inventive merit. The integration of artificial intelligence, micro-robotics, and advanced imaging represents predictable technological extensions of existing medical device design principles, thereby rendering potential patent claims obvious and unpatentable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,209
TitleDevices and methods for treating blocked blood vessels
Assignee(s)SHANGHAI WALLABY MEDICAL TECHNOLOGIES CO., INC.